Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › NK-3 receptor antagonists for therapeutic treatment of leptin-related disease

NK-3 receptor antagonists for therapeutic treatment of leptin-related disease

US Patent 11478472 · Granted Oct 25, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body f2025
NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body f2025
Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deu2024
Piperidine derivatives as METTL3 inhibitors2024
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
Deuterated fezolinetant2021
Substituted pyrrolidines as G-protein coupled receptor 43 agonists2021
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as2021
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as2021
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2020
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2020